Cargando…
Effects of canagliflozin on NT-proBNP stratified by left ventricular diastolic function in patients with type 2 diabetes and chronic heart failure: a sub analysis of the CANDLE trial
BACKGROUND: Identification of the effective subtypes of treatment for heart failure (HF) is an essential topic for optimizing treatment of the disorder. We hypothesized that the beneficial effect of SGLT2 inhibitors (SGLT2i) on the levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) might...
Autores principales: | Kusunose, Kenya, Imai, Takumi, Tanaka, Atsushi, Dohi, Kaoru, Shiina, Kazuki, Yamada, Takahisa, Kida, Keisuke, Eguchi, Kazuo, Teragawa, Hiroki, Takeishi, Yasuchika, Ohte, Nobuyuki, Yamada, Hirotsugu, Sata, Masataka, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442416/ https://www.ncbi.nlm.nih.gov/pubmed/34521417 http://dx.doi.org/10.1186/s12933-021-01380-w |
Ejemplares similares
-
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013) -
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010) -
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice
por: Rahadian, Arief, et al.
Publicado: (2020) -
The Ability of Heart Failure Specialists to Accurately Predict NT-proBNP Levels Based on Clinical Assessment and a Previous NT-proBNP Measurement
por: Sedlak, Tara L, et al.
Publicado: (2008)